12:00 AM
Jan 10, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Invega paliperidone ER regulatory update

The European Commission approved a label expansion for Invega paliperidone extended-release tablets to include the treatment of psychotic or manic...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >